# FDA recall D-1362-2014

> **Pharmakon Pharmaceuticals** · Class I · drug recall initiated 2014-03-26.

## Product

Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.

## Reason for recall

Superpotent Drug: Product contains twice the stated amount of midazolam.

## Distribution

IN

## Key facts

- **Recall number:** D-1362-2014
- **Recalling firm:** Pharmakon Pharmaceuticals
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-03-26
- **Report date:** 2014-06-18
- **Termination date:** 2014-07-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Noblesville, IN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1362-2014

## Citation

> AI Analytics. FDA recall D-1362-2014. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1362-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*